Wilson Rebecca L, Kirwan Cliona C, O'Donoghue Joe M, Linforth Richard A, Johnson Richard K, Harvey James R
Nightingale Centre, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK.
Nightingale Centre, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Cancer Research Centre, Manchester Academic Health Science Centre, University of Manchester, 555 Wilmslow Road, Manchester, M20 4GJ, UK.
Eur J Surg Oncol. 2022 Jan;48(1):73-81. doi: 10.1016/j.ejso.2021.10.026. Epub 2021 Nov 6.
Approximately 60% of implant-based breast reconstructions (IBBR) are performed with an acellular dermal matrix (ADM), for which, reliable, good quality long-term outcome data is limited. In a retrospective multicentre cohort study, we aimed to determine long-term aesthetic and quality of life outcomes of IBBR with ADM (Strattice™) compared to a submuscular technique.
Capsular contracture (Baker III/IV capsule) was determined by clinical examination by an independent researcher. Quality of life was assessed using BREAST-Q and aesthetic outcome by photographic assessment from a breast surgeon, breast care nurse and lay person, blinded to reconstruction type.
We recruited 117 (51 bilateral) patients with ADM reconstructions, median follow-up 62 months (range 29-113) and 49 patients (16 bilateral) with submuscular reconstructions, median follow-up 76 months (range 38-111). 17 (10.1%) ADM reconstructions were Baker 3/4 compared to six (9.2%) submuscular (p = 0.85). Of the Baker 1/2 reconstructions six (3.6%) ADM and eight (13.6%) submuscular had previously undergone revision surgery to correct capsular contracture (p = 0.01). Combining both findings gave an estimated rate of capsular contracture of 13.6% in the ADM group and 21.2% in the submuscular (p = 0.14). A higher mean score for satisfaction with breasts was demonstrated when comparing ADM to submuscular (62 and 55, respectively; p = 0.01) but no significant difference in other BREAST-Q domains. The mean 'general satisfaction' score was higher in the ADM group for all three photograph assessors.
This study provides evidence of improved aesthetic outcome and reduction in capsular contracture with ADM reconstruction when compared to submuscular, consistent over long-term follow-up.
约60%的乳房植入物重建术(IBBR)采用脱细胞真皮基质(ADM)进行,而关于其可靠、高质量的长期结局数据有限。在一项回顾性多中心队列研究中,我们旨在确定与肌下技术相比,采用ADM(Strattice™)进行IBBR的长期美学效果和生活质量结局。
由一名独立研究人员通过临床检查确定包膜挛缩(贝克III/IV级包膜)。使用BREAST-Q评估生活质量,并由一名乳腺外科医生、一名乳腺护理护士和一名外行人在不知重建类型的情况下通过摄影评估美学效果。
我们招募了117例(51例双侧)接受ADM重建的患者,中位随访时间为62个月(范围29 - 113个月),以及49例(16例双侧)接受肌下重建的患者,中位随访时间为76个月(范围38 - 111个月)。17例(10.1%)ADM重建为贝克3/4级,而肌下重建为6例(9.2%)(p = 0.85)。在贝克1/2级重建中,6例(3.6%)ADM重建和8例(13.6%)肌下重建此前曾接受修复手术以纠正包膜挛缩(p = 0.01)。综合这两项结果,ADM组的包膜挛缩估计发生率为13.6%,肌下组为21.2%(p = 0.14)。与肌下重建相比,ADM重建时对乳房满意度的平均得分更高(分别为62分和55分;p = 0.01),但在其他BREAST-Q领域无显著差异。对于所有三名照片评估者,ADM组的“总体满意度”平均得分更高。
本研究提供的证据表明,与肌下重建相比,ADM重建在长期随访中美学效果更佳,包膜挛缩发生率更低。